Journey Colab is pioneering a new model of addiction care that integrates psychedelic therapeutics with comprehensive support systems, including psychotherapy and community engagement. The company aims to leverage the scientific potential of psychedelics to provide lasting relief for individuals grappling with addiction, particularly alcohol use disorder. Their approach involves establishing a network of Centers of Excellence in collaboration with select addiction treatment centers across the U.S., which will facilitate real-world research and the development of psychedelic therapies. One of their key compounds in development is JOUR-5700, a Mescaline HCl formulation, which is designed to activate serotonin receptors associated with various cognitive and emotional processes, potentially leading to neuroplasticity and improved treatment outcomes.

The focus on Mescaline HCl reflects Journey Colab's commitment to exploring innovative solutions for addiction treatment. Early research indicates that this compound may offer a safer and more insightful therapeutic experience compared to other psychedelics, promoting mental clarity and emotional connectedness. This could enhance the effectiveness of psychotherapy, allowing patients to engage more deeply in their recovery process. By prioritizing equitable access to care and involving community stakeholders, including Indigenous populations, Journey Colab is not only addressing the urgent need for effective addiction treatments but also fostering a collaborative and inclusive approach to healthcare.

United States

Journey Colab is unlocking the science of psychedelics to build a new model of addiction care combining the potential of neuroplasticity-promoting therapeutics with psychotherapy and community support. Our lead compound is synthetic Mescaline HCl for patients with alcohol use disorder (AUD), who are in desperate need of durable remission from this chronic, relapsing condition. Through our unique stakeholder structure, we have built an experienced team dedicated to our mission of creating scientifically rigorous and clinically validated treatments and improving equitable access to care.

Journey Colab

Company Details